Biotechnology | Healthcare
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosis management, orthopedics, pain management, and fever; and betacoronavirus, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, hepatitis A, and varicella vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc for the manufacture and supply of Azacitidine injection; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Market Cap
28879147008
Current Price
461.5
52 Week Range
129.89 - 581.9
Previous Close
441.15
Open
446.9
Industry
Biotechnology
Sector
Healthcare
Address
B-1 Extension/G-3, Mohan Co-operative Industrial Estate Mathura Road, New Delhi, 110044, India
Phone
+91-11416-79000
Fax
+91-11416-79015
Website
https://www.panaceabiotec.com
Day Low
443.0
Day High
465.9
Dividend Yield
PE Ratio
Earnings Per Share
-1.32
Beta
0.454
EBITDA
-259100000
Book Value
136.923
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Dr. Rajesh Jain Ph.D. | Chairman of the Board & MD | 60 | 1964 |
Mr. Sandeep Jain | Joint MD & Executive Director | 58 | 1966 |
Mr. Devender Gupta | CFO & Head of Information Technology | 51 | 1973 |
Dr. Khalid Al Syed | Chief Scientific Officer | 49 | 1975 |
Mr. Vinod Goel | Group CFO, Head of Legal, Company Secretary & Compliance Officer | 59 | 1965 |
Mr. Ankesh Jain | Whole-Time Director | 35 | 1989 |
Dr. Rajeeva Kumar Mangalum | Chief Operating Officer | 63 | 1961 |
Naresh Chand Gupta | General Manager of Accounts & Taxation | - | - |
Mr. Ashish Jain | Chief Information Officer | - | - |
Mr. Gurinder Pal Singh | Senior Vice President of Sales | 57 | 1967 |
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.